Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1656 in Diabetic Patients with COVID-19
NCT04516759Phase 2Completed
- Sponsor
- St George Street Capital
- Start
- Aug 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of AZD1656 in coronavirus disease 2019 (COVID-19), sponsored by St George Street Capital. Started Aug 2020; status: completed.
02
Drugs
AZD1656
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04516759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04516759.